Cho, Chamlee https://orcid.org/0009-0002-3155-1932
Kim, Beomsu https://orcid.org/0000-0001-7410-4273
Kim, Dan Say
Hwang, Mi Yeong https://orcid.org/0000-0002-8208-7925
Shim, Injeong https://orcid.org/0000-0002-1001-0945
Song, Minku
Lee, Yeong Chan https://orcid.org/0000-0002-2093-3161
Jung, Sang-Hyuk https://orcid.org/0000-0003-4116-3327
Cho, Sung Kweon https://orcid.org/0000-0002-5929-7932
Park, Woong-Yang
Myung, Woojae https://orcid.org/0000-0001-9985-2032
Kim, Bong-Jo
Do, Ron https://orcid.org/0000-0002-3144-3627
Choi, Hyon K.
Merriman, Tony R. https://orcid.org/0000-0003-0844-8726
Kim, Young Jin https://orcid.org/0000-0002-4132-4437
Won, Hong-Hee https://orcid.org/0000-0001-5719-0552
Article History
Received: 8 August 2023
Accepted: 10 April 2024
First Online: 24 April 2024
Competing interests
: W.-Y.P. is an employee of Geninus though this is unrelated to this work. R.D. reported receiving grants from AstraZeneca, grants and non-financial support from Goldfinch Bio, being a scientific co-founder, consultant, and equity holder for Pensieve Health, and being a consultant for Variant Bio, all not related to this work. The remaining authors declare no competing interests.